BRYN MAWR TRUST Co grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.5% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,064 shares of the medical instruments supplier’s stock after purchasing an additional 65 shares during the period. BRYN MAWR TRUST Co’s holdings in DENTSPLY SIRONA were worth $782,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in shares of DENTSPLY SIRONA by 2.7% during the first quarter. Vanguard Group Inc. now owns 22,165,069 shares of the medical instruments supplier’s stock worth $1,383,988,000 after acquiring an additional 584,536 shares during the period. BlackRock Inc. increased its position in shares of DENTSPLY SIRONA by 3,103.7% during the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after acquiring an additional 13,457,730 shares during the period. State Street Corp increased its position in shares of DENTSPLY SIRONA by 0.4% during the first quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock worth $620,136,000 after acquiring an additional 36,012 shares during the period. Principal Financial Group Inc. increased its position in shares of DENTSPLY SIRONA by 22.3% during the second quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock worth $419,802,000 after acquiring an additional 1,181,547 shares during the period. Finally, Veritas Asset Management LLP increased its position in shares of DENTSPLY SIRONA by 2.6% during the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after acquiring an additional 157,616 shares during the period. Institutional investors own 93.87% of the company’s stock.

A number of analysts have recently weighed in on XRAY shares. UBS AG reaffirmed a “neutral” rating and set a $59.00 price objective (down previously from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. BidaskClub lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Jefferies Group LLC cut their price objective on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a research report on Wednesday, August 23rd. Stifel Nicolaus reaffirmed a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Finally, Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 14th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $65.73.

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded up 0.95% during midday trading on Wednesday, hitting $58.40. 87,677 shares of the stock traded hands. DENTSPLY SIRONA Inc. has a one year low of $52.54 and a one year high of $65.68. The stock’s market cap is $13.40 billion. The firm has a 50-day moving average price of $56.98 and a 200 day moving average price of $61.67.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same quarter in the prior year, the firm earned $0.76 EPS. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

ILLEGAL ACTIVITY WARNING: “BRYN MAWR TRUST Co Grows Holdings in DENTSPLY SIRONA Inc. (XRAY)” was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/20/bryn-mawr-trust-co-grows-holdings-in-dentsply-sirona-inc-xray.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.